Active, Not Recruiting
A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers
NCT06496568
- Conditions
- PIK3CA-Mutated Cancers
- Locations
-
- Vanderbilt-Ingram Cancer Ctr Nashville, Tennessee, United States
- BC Cancer Vancouver Centre Vancouver, British Columbia, Canada
- Princess Margaret Cancer Center Toronto, Ontario, Canada
- Jewish General Hospital Montreal, Quebec, Canada